2022 AANextra - Tuesday Issue

Page 1

AANextra AN OFFICIAL PUBLICATION OF THE AMERICAN ACADEMY OF NEUROLOGY

Tuesday, April 5, 2022

IMPORTANT CLINICAL TRIALS SHOWCASED IN TODAY'S PLENARY The Clinical Trials Plenary Session is set to take place this morning from 9:15 a.m. to 11:30 a.m. in Hall 4A. The session will showcase experts presenting the latest updates within several clinical trials that affect patient care, conducted over the course of the last year and identified from other society meetings.

A Phase 3 Trial Evaluating the Efficacy, Duration of Effect, and Safety of DaxibotulinumtoxinA for Injection in the Treatment of Cervical Dystonia

Robert A. Hauser, MD, MBA, FAAN University of South Florida

Moderators

Relapse Rate and Time to First Relapse Were Improved with Ublituximab vs Teriflunomide in the Phase 3 ULTIMATE I and ULTIMATE II Studies in Patients with Relapsing Multiple Sclerosis (RMS) Lawrence Steinman, MD, FAAN Stanford Medicine

AAN Science Committee Members

H E Hinson, MD, MCR, FAAN Oregon Health & Science University

Reena Parada Thomas, MD Stanford Cancer Center

Efficacy and Safety of Ravulizumab, a Long-acting Terminal Complement Inhibitor, in Adults with Antiacetylcholine Reception Antibodypositive Generalized Myasthenia Gravis: Results from the Phase 3 CHAMPION MG Study Tuan Hoang Vu, MD University of South Florida

What is your aha moment from the Clinical Trials Plenary Session? Join the conversation at #AANAM.

INSIDE

4

Today Is National Institutes of Health Day—Take Part in These Special Events!

5

IDEAS Panel to Discuss New Online Anti-racism Education Program

6

Latest Innovations of Significance Highlighted in Emerging Science Abstracts

Efficacy and Safety Outcomes in Patients with Chronic Traumatic Brain Injury: Final Analysis of the Phase 2 Stemtra Trial Peter J. McAllister, MD, FAAN New England Institute for Neurology and Headache

Live Fireside Chat to Follow Clinical Trials Plenary Session Head over to the Research Connections Learner Engagement Center in Hall 4C-4 from 11:45 a.m. to 12:15 p.m. to engage with and ask questions of plenary moderators and presenters during the live, 30-minute fireside chat!

MR CLEAN-NO IV: Intravenous Treatment Followed by Endovascular Treatment Versus Direct Endovascular Treatment for Acute Ischemic Stroke Caused by a Proximal Intracranial Occlusion-study Protocol for a Randomized Clinical Trial Natalie LeCouffe, MD Amsterdam UMC

Clinical Efficacy of ONC201 in Recurrent H3 K27M-Mutant Diffuse Midline Glioma Patients Isabel ArrillagaRomany, MD Massachusetts General Hospital

Efficacy and Safety of Trofinetide for the Treatment of Rett Syndrome: Results From the Pivotal Phase 3 LAVENDER Study Jeffrey Neul, MD, PhD Vanderbilt University Medical Center


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.